{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:53:54Z","timestamp":1774572834638,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the 2025 Undergraduate Innovation and Entrepreneurship Training Program of Zhengzhou University","award":["202510459223"],"award-info":[{"award-number":["202510459223"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170738"],"award-info":[{"award-number":["82170738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Henan Province Young and middle-aged health science and technology innovation Talents Project","award":["JQRC2023006"],"award-info":[{"award-number":["JQRC2023006"]}]},{"name":"the Henan Province Natural Science Foundation","award":["242300421085"],"award-info":[{"award-number":["242300421085"]}]},{"name":"the Excellent Young Talents Program of Zhengzhou University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-38437-3","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T22:34:35Z","timestamp":1771626875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of the gut mycobiome in patients with membranous nephropathy"],"prefix":"10.1038","volume":"16","author":[{"given":"Yingxin","family":"Zhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanzheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"38437_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","volume":"7","author":"P Ronco","year":"2021","unstructured":"Ronco, P. et al. Membranous nephropathy. Nat. Rev. Dis. Primers. 7, 69. https:\/\/doi.org\/10.1038\/s41572-021-00303-z (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"38437_CR2","doi-asserted-by":"publisher","first-page":"593288","DOI":"10.3389\/fimmu.2021.593288","volume":"12","author":"V Tesar","year":"2021","unstructured":"Tesar, V. & Hruskova, Z. Autoantibodies in the Diagnosis, Monitoring, and treatment of membranous nephropathy. Front. Immunol. 12, 593288. https:\/\/doi.org\/10.3389\/fimmu.2021.593288 (2021).","journal-title":"Front. Immunol."},{"key":"38437_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/postgradmedj-2018-135729","volume":"95","author":"KC Keri","year":"2019","unstructured":"Keri, K. C., Blumenthal, S., Kulkarni, V., Beck, L. & Chongkrairatanakul, T. Primary membranous nephropathy: comprehensive review and historical perspective. Postgrad. Med. J. 95, 23\u201331. https:\/\/doi.org\/10.1136\/postgradmedj-2018-135729 (2019).","journal-title":"Postgrad. Med. J."},{"key":"38437_CR4","doi-asserted-by":"publisher","unstructured":"Wang, M., Yang, J., Fang, X., Lin, W. & Yang, Y. Membranous nephropathy: pathogenesis and treatments. MedComm (2020). 5 (e614). https:\/\/doi.org\/10.1002\/mco2.614 (2024).","DOI":"10.1002\/mco2.614"},{"key":"38437_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/s0270-9295(03)00049-4","volume":"23","author":"RJ Glassock","year":"2003","unstructured":"Glassock, R. J. Diagnosis and natural course of membranous nephropathy. Semin Nephrol. 23, 324\u2013332. https:\/\/doi.org\/10.1016\/s0270-9295(03)00049-4 (2003).","journal-title":"Semin Nephrol."},{"key":"38437_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1681\/ASN.2020071082","volume":"32","author":"S Sethi","year":"2021","unstructured":"Sethi, S. New antigens in membranous nephropathy. J. Am. Soc. Nephrol. 32, 268\u2013278. https:\/\/doi.org\/10.1681\/ASN.2020071082 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"38437_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100, S1\u2013276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021 (2021).","journal-title":"Kidney Int."},{"key":"38437_CR8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1148\/radiology.215.3.r00ma07689","volume":"215","author":"P Cluzel","year":"2000","unstructured":"Cluzel, P. et al. Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology 215, 689\u2013693. https:\/\/doi.org\/10.1148\/radiology.215.3.r00ma07689 (2000).","journal-title":"Radiology"},{"key":"38437_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou, K. et al. Microbiota in health and diseases. Signal. Transduct. Target. Ther. 7, 135. https:\/\/doi.org\/10.1038\/s41392-022-00974-4 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"38437_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12967-018-1756-4","volume":"17","author":"Y-Y Chen","year":"2019","unstructured":"Chen, Y-Y. et al. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease. J. Transl Med. 17, 5. https:\/\/doi.org\/10.1186\/s12967-018-1756-4 (2019).","journal-title":"J. Transl Med."},{"key":"38437_CR11","doi-asserted-by":"publisher","first-page":"2001936","DOI":"10.1002\/advs.202001936","volume":"7","author":"Z Ren","year":"2020","unstructured":"Ren, Z. et al. Alterations of the human gut Microbiome in chronic kidney disease. Adv. Sci. (Weinh). 7, 2001936. https:\/\/doi.org\/10.1002\/advs.202001936 (2020).","journal-title":"Adv. Sci. (Weinh)"},{"key":"38437_CR12","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","volume":"69","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut 69, 2131\u20132142. https:\/\/doi.org\/10.1136\/gutjnl-2019-319766 (2020).","journal-title":"Gut"},{"key":"38437_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nri3684","volume":"14","author":"DM Underhill","year":"2014","unstructured":"Underhill, D. M. & Iliev, I. D. The mycobiota: interactions between commensal fungi and the host immune system. Nat. Rev. Immunol. 14, 405\u2013416. https:\/\/doi.org\/10.1038\/nri3684 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"38437_CR14","doi-asserted-by":"publisher","first-page":"e969","DOI":"10.1016\/S2666-5247(22)00203-8","volume":"3","author":"F Zhang","year":"2022","unstructured":"Zhang, F., Aschenbrenner, D., Yoo, J. Y. & Zuo, T. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial Microbiome assembly. Lancet Microbe. 3, e969\u2013e983. https:\/\/doi.org\/10.1016\/S2666-5247(22)00203-8 (2022).","journal-title":"Lancet Microbe"},{"key":"38437_CR15","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.cell.2024.04.043","volume":"187","author":"Q Yan","year":"2024","unstructured":"Yan, Q. et al. A genomic compendium of cultivated human gut fungi characterizes the gut mycobiome and its relevance to common diseases. Cell 187, 2969\u20132989e24. https:\/\/doi.org\/10.1016\/j.cell.2024.04.043 (2024).","journal-title":"Cell"},{"key":"38437_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.chom.2024.12.006","volume":"33","author":"J Wu","year":"2025","unstructured":"Wu, J. et al. The intestinal fungus Aspergillus tubingensis promotes polycystic ovary syndrome through a secondary metabolite. Cell. Host Microbe. 33, 119\u2013136e11. https:\/\/doi.org\/10.1016\/j.chom.2024.12.006 (2025).","journal-title":"Cell. Host Microbe"},{"key":"38437_CR17","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.xcrm.2024.101775","volume":"5","author":"W Gou","year":"2024","unstructured":"Gou, W. et al. The Temporal dynamics of the gut mycobiome and its association with cardiometabolic health in a nationwide cohort of 12,641 Chinese adults. Cell. Rep. Med. 5, 101775. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101775 (2024).","journal-title":"Cell. Rep. Med."},{"key":"38437_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12967-024-05004-1","volume":"22","author":"Y Ren","year":"2024","unstructured":"Ren, Y. et al. Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes. J. Transl Med. 22, 202. https:\/\/doi.org\/10.1186\/s12967-024-05004-1 (2024).","journal-title":"J. Transl Med."},{"issue":"Database issue","key":"38437_CR19","doi-asserted-by":"publisher","first-page":"D259","DOI":"10.1093\/nar\/gky1022","volume":"47","author":"RH Nilsson","year":"2019","unstructured":"Nilsson, R. H. et al. The UNITE database for molecular identification of fungi: handling dark taxa and parallel taxonomic classifications. Nucleic Acids Res. 47 (Database issue), D259\u2013D264. https:\/\/doi.org\/10.1093\/nar\/gky1022 (2019).","journal-title":"Nucleic Acids Res."},{"key":"38437_CR20","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1093\/jnci\/djn326","volume":"100","author":"MS Pepe","year":"2008","unstructured":"Pepe, M. S., Feng, Z., Janes, H., Bossuyt, P. M. & Potter, J. D. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J. Natl. Cancer Inst. 100, 1432\u20131438. https:\/\/doi.org\/10.1093\/jnci\/djn326 (2008).","journal-title":"J. Natl. Cancer Inst."},{"key":"38437_CR21","doi-asserted-by":"publisher","unstructured":"Guo, H. et al. The cutoff value and prognosis of anti-PLA2R antibody for idiopathic membranous nephropathy: A single-center retrospective study in China. Ren. Fail. 45, 2253922. https:\/\/doi.org\/10.1080\/0886022X.2023.2253922","DOI":"10.1080\/0886022X.2023.2253922"},{"key":"38437_CR22","doi-asserted-by":"publisher","first-page":"e2201581","DOI":"10.1002\/advs.202201581","volume":"9","author":"J Shang","year":"2022","unstructured":"Shang, J. et al. Gut Microbiome analysis can be used as a noninvasive diagnostic tool and plays an essential role in the onset of membranous nephropathy. Adv. Sci. (Weinh). 9, e2201581. https:\/\/doi.org\/10.1002\/advs.202201581 (2022).","journal-title":"Adv. Sci. (Weinh)"},{"key":"38437_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bph.16219","volume":"181","author":"H Miao","year":"2024","unstructured":"Miao, H. et al. Lactobacillus species ameliorate membranous nephropathy through inhibiting the Aryl hydrocarbon receptor pathway via tryptophan-produced Indole metabolites. Br. J. Pharmacol. 181, 162\u2013179. https:\/\/doi.org\/10.1111\/bph.16219 (2024).","journal-title":"Br. J. Pharmacol."},{"key":"38437_CR24","doi-asserted-by":"publisher","first-page":"104359","DOI":"10.1016\/j.micpath.2020.104359","volume":"147","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome. Microb. Pathog. 147, 104359. https:\/\/doi.org\/10.1016\/j.micpath.2020.104359 (2020).","journal-title":"Microb. Pathog"},{"key":"38437_CR25","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1136\/gutjnl-2021-326298","volume":"71","author":"M Shuai","year":"2022","unstructured":"Shuai, M. et al. Mapping the human gut mycobiome in middle-aged and elderly adults: multiomics insights and implications for host metabolic health. Gut 71, 1812\u20131820. https:\/\/doi.org\/10.1136\/gutjnl-2021-326298 (2022).","journal-title":"Gut"},{"key":"38437_CR26","doi-asserted-by":"publisher","first-page":"e66019","DOI":"10.1371\/journal.pone.0066019","volume":"8","author":"C Hoffmann","year":"2013","unstructured":"Hoffmann, C. et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One. 8, e66019. https:\/\/doi.org\/10.1371\/journal.pone.0066019 (2013).","journal-title":"PLoS One"},{"key":"38437_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/21505594.2016.1247140","volume":"8","author":"HE Hallen-Adams","year":"2017","unstructured":"Hallen-Adams, H. E. & Suhr, M. J. Fungi in the healthy human Gastrointestinal tract. Virulence 8, 352\u2013358. https:\/\/doi.org\/10.1080\/21505594.2016.1247140 (2017).","journal-title":"Virulence"},{"key":"38437_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12916-023-03095-z","volume":"21","author":"Q Liu","year":"2023","unstructured":"Liu, Q. et al. Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study. BMC Med. 21, 409. https:\/\/doi.org\/10.1186\/s12916-023-03095-z (2023).","journal-title":"BMC Med."},{"key":"38437_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/gutjnl-2018-317178","volume":"68","author":"OO Coker","year":"2019","unstructured":"Coker, O. O. et al. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut 68, 654\u2013662. https:\/\/doi.org\/10.1136\/gutjnl-2018-317178 (2019).","journal-title":"Gut"},{"key":"38437_CR30","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut, B. et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature 574, 264\u2013267. https:\/\/doi.org\/10.1038\/s41586-019-1608-2 (2019).","journal-title":"Nature"},{"key":"38437_CR31","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3389\/fmicb.2019.01575","volume":"10","author":"S Raimondi","year":"2019","unstructured":"Raimondi, S. et al. Longitudinal survey of fungi in the human gut: ITS Profiling, Phenotyping, and colonization. Front. Microbiol. 10, 1575. https:\/\/doi.org\/10.3389\/fmicb.2019.01575 (2019).","journal-title":"Front. Microbiol."},{"key":"38437_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s40168-017-0373-4","volume":"5","author":"AK Nash","year":"2017","unstructured":"Nash, A. K. et al. The gut mycobiome of the human Microbiome project healthy cohort. Microbiome 5, 153. https:\/\/doi.org\/10.1186\/s40168-017-0373-4 (2017).","journal-title":"Microbiome"},{"key":"38437_CR33","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00467-008-0813-2","volume":"23","author":"A Soylu","year":"2008","unstructured":"Soylu, A. et al. Saccharomyces boulardii prevents oral-poliovirus vaccine-induced IgA nephropathy in mice. Pediatr. Nephrol. 23, 1287\u20131291. https:\/\/doi.org\/10.1007\/s00467-008-0813-2 (2008).","journal-title":"Pediatr. Nephrol."},{"key":"38437_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2147\/PPA.S97852","volume":"10","author":"B Kowalewska","year":"2016","unstructured":"Kowalewska, B., Zorena, K., Szmigiero-Kawko, M., W\u0105\u017c, P. & My\u015bliwiec, M. Higher diversity in fungal species discriminates children with type 1 diabetes mellitus from healthy control. Patient Prefer Adherence. 10, 591\u2013599. https:\/\/doi.org\/10.2147\/PPA.S97852 (2016).","journal-title":"Patient Prefer Adherence"},{"key":"38437_CR35","doi-asserted-by":"publisher","first-page":"103557","DOI":"10.1016\/j.ebiom.2021.103557","volume":"71","author":"S Shah","year":"2021","unstructured":"Shah, S. et al. Alterations of the gut mycobiome in patients with MS. EBioMedicine 71, 103557. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103557 (2021).","journal-title":"EBioMedicine"},{"key":"38437_CR36","doi-asserted-by":"publisher","first-page":"eaaf9044","DOI":"10.1126\/scitranslmed.aaf9044","volume":"9","author":"TR Chiaro","year":"2017","unstructured":"Chiaro, T. R. et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci. Transl Med. 9, eaaf9044. https:\/\/doi.org\/10.1126\/scitranslmed.aaf9044 (2017).","journal-title":"Sci. Transl Med."},{"key":"38437_CR37","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol, H. et al. Fungal microbiota dysbiosis in IBD. Gut 66, 1039\u20131048. https:\/\/doi.org\/10.1136\/gutjnl-2015-310746 (2017).","journal-title":"Gut"},{"key":"38437_CR38","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/jcm12051948","volume":"12","author":"L Voroneanu","year":"2023","unstructured":"Voroneanu, L. et al. Gut microbiota in chronic kidney disease: from composition to modulation towards better Outcomes-A systematic review. J. Clin. Med. 12, 1948. https:\/\/doi.org\/10.3390\/jcm12051948 (2023).","journal-title":"J. Clin. Med."},{"key":"38437_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41387-024-00328-9","volume":"14","author":"Y Cai","year":"2024","unstructured":"Cai, Y. et al. Diabetic foot exacerbates gut mycobiome dysbiosis in adult patients with type 2 diabetes mellitus: revealing diagnostic markers. Nutr. Diabetes. 14, 71. https:\/\/doi.org\/10.1038\/s41387-024-00328-9 (2024).","journal-title":"Nutr. Diabetes"},{"key":"38437_CR40","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s11427-023-2458-1","volume":"67","author":"S Jiang","year":"2024","unstructured":"Jiang, S. et al. Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver disease. Sci. China Life Sci. 67, 1183\u20131198. https:\/\/doi.org\/10.1007\/s11427-023-2458-1 (2024).","journal-title":"Sci. China Life Sci."},{"key":"38437_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.gastro.2020.09.014","volume":"160","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. Population-Level configurations of gut mycobiome across 6 ethnicities in urban and rural China. Gastroenterology 160, 272\u2013286e11. https:\/\/doi.org\/10.1053\/j.gastro.2020.09.014 (2021).","journal-title":"Gastroenterology"},{"key":"38437_CR42","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3389\/fmicb.2014.00587","volume":"5","author":"S Quercia","year":"2014","unstructured":"Quercia, S. et al. From lifetime to evolution: timescales of human gut microbiota adaptation. Front. Microbiol. 5, 587. https:\/\/doi.org\/10.3389\/fmicb.2014.00587 (2014).","journal-title":"Front. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38437-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38437-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38437-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:02:13Z","timestamp":1774569733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38437-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38437"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38437-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by The First Affiliated Hospital of Zhengzhou University Ethics Review Committee (2019-KY-361, 2023-KY-0285). All the participants signed written informed consents to participate in this project.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"9973"}}